NEW STUDIES ADDED
Title: Electromagnetic Fields for the Regulation of Neural Stem Cells
Location in PEMF Global Library: Stem Cell Folder
Applied Frequencies: .5-30 Hz
Available in: Omnium1 2.0, iMRS Prime
Abstract: Localized magnetic fields could easily penetrate the scalp, skull, and meninges, thus inducing an electrical current in both the central and peripheral nervous systems, which is primarily used in transcranial magnetic stimulation (TMS) for inducing specific effects on different regions or cells that play roles in various brain activities. Studies of repetitive transcranial magnetic stimulation (rTMS) have led to novel attractive therapeutic approaches. Neural stem cells (NSCs) in adult human brain are able to selfrenew and possess multi-differential ability to maintain homeostasis and repair damage after acute central nervous system. In the present review, we summarized the electrical activity of NSCs and the fundamental mechanism of electromagnetic fields and their effects on regulating NSC proliferation, differentiation, migration, and maturation. Although it was authorized for the rTMS use in resistant depression patients by US FDA, there are still unveiling mechanism and limitations for rTMS in clinical applications of acute central nervous system injury, especially on NSC regulation as a rehabilitation strategy. More in-depth studies should be performed to provide detailed parameters and mechanisms of rTMS in further studies, making it a powerful tool to treat people who are surviving with acute central nervous system injuries.
Conclusion: Despite its limitations, TMS is a promising therapeutic tool for many refractory neural diseases. It is non-invasive and has a clear positive influence on different parts of the brain, especially on NSCs. Nevertheless, NSCs are promising for traumatic, degenerative, and psychiatric diseases. All these findings contributed to TMS being deemed as a brain science technology of the 21st century. Clinical applications must be expanded to collect more data regarding the modality. We believe that the efforts of excellent researchers will accelerate the development of TMS applications, making it a powerful tool to treat people who are surviving with painful diseases.
Title: Utilizing Pulsed Electromagnetic Field (PEMF) Therapy (Diapulse®) for Drug Free Pain Management to Eliminate Reliance on Opioids for Non-Malignant Chronic Pain: A literature Review and Proposal for Pilot Study
Location in PEMF Global Library: Pain Folder
Applied Frequencies: 600 & 800 Hz
Available in: iMRS Prime Trial
Abstract: The Federal and State governments have declared the presence of an opioid addiction pandemic in the United States claiming the lives of more than 55,000 in 2015 (Rudd RA, Seth P, David F and Scholl L. 2016). The pharmaceutical manufacturers of the numerous FDA-approved opioid drugs are raking in more than $5 billion per year with about 2 million chronic pain sufferers addicted. The irony of this narcotic use and abuse conundrum is the existence of evidence-based technology for drug-free pain management which is not covered for reimbursement among public and private third-party payers. Therefore, this paper is presented to propose a pilot study to demonstrate the efficacy of resolving the chronic inflammation, edema and ischemia that causes non-malignant chronic pain with PEMF therapy, a non-invasive, non-thermal radio transmission of electrical impulses, thereby invalidating the leg.
Conclusion: It is well known that non-malignant chronic pain can emanate from any area of the human body arising from some chronic inflammatory process that is either endogenous (autoimmune disorder or various types of injuries) or exogenous (pathogenic or foreign material invasion). The latter can be treated by attacking the pathogen or removing the foreign material while the former is more insidious with elusive resolutions and requires continuous management. Therefore, by approaching this pandemic health problem in treating such inflammation as a major underlying etiology of non-malignant chronic pain with a non-invasive modality such as drug-free PEMF therapy, we could make a substantial dent in reducing indiscriminate prescriptions for opioids and reducing its current level of consumption. To accomplish this goal there needs to be a paradigm shift from chronic pain management to chronic inflammation management.
Title: Treating Herpes Zoster with Magnetic Fields
Location in PEMF Global Library: Herpes Folder
Applied Frequencies: Low frequency 30Hz
Available in: iMRS Prime Trial, and similar range to Omnium1 2.0, iMRS Prime
Abstract: This study included 40 patients with Herpes Zoster who were treated with low frequency and low-intensity magnetic fields. Seventy seven percent of the treated patients were older than 50 years; and 80% of them were women. 62% of the patients visited a doctor on the third or fourth day of their disease, with lesions in various areas, the intercostal region being the most frequent, accounting for 67% of the cases. One hundred percent of the patients felt pain.
Conclusion: All patients received ten treatment sessions. No new lesions were found after the first treatment, and pain was remarkably reduced. 55% of patients recovered from their affliction after 4 – 6 sessions, while none needed more than 10 sessions. This procedure proved efficient in the treatment of Herpes zoster in all patients treated. From an economic point of view, this treatment with magnetic fields costs less than conventional treatments. The low-frequency and low-intensity magnetic field proved effective in treating herpes zoster in the studied zones. Treating herpes zoster with magnetic fields is without cost for the patient; nor does it cause discomfort in comparison with conventional treatments. Magnetotherapy is a new option to treat this disorder. It produces superior results over other physical therapies, including drugs. Magnetotheraphy should soon take its proper place in the health system because of its great efficacy, the absence of toxicity, and the low cost involved in its use.
Title: Short-term effects of pulsed electromagnetic Fields after physical exercise are dependent on autonomic tone before exposure
Location in PEMF Global Library: Athletic Performance Folder, HRV – Heart Rate Variability Folder
Applied Frequencies: 50 Hz
Available in: iMRS Prime Trial
Abstract: The aim of this study is to examine the instantaneous and short-term effects of a PEMF therapy after exercise, and to measure the impact of different electromagnetic Field strengths on a range of physiological parameters, especially the autonomic nervous systems, determined by heart rate variability (HRV) as well as their influence on subjects’ general feeling of well-being.
Conclusion: The effects of PEMFs on human autonomic nervous system were found to be significant using heart rate variability measurements. The PEMF treatment of healthy individuals shows dosage-dependent effects on the autonomic nervous system. The subjects’ constitutional VLF power plays an important role on the outcome and is recommended to be considered to select Field strength in PEMF therapy. At this frequency parameter there was no change in sense of wellbeing.